These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 655276)

  • 1. Levodopa-induced psychosis: a kindling phenomenon.
    Moskovitz C; Moses H; Klawans HL
    Am J Psychiatry; 1978 Jun; 135(6):669-75. PubMed ID: 655276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dream phenomena induced by chronic levodopa therapy.
    Sharf B; Moskovitz C; Lupton MD; Klawans HL
    J Neural Transm; 1978; 43(2):143-51. PubMed ID: 104005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between age and subtypes of psychotic symptoms in Parkinson's disease.
    Kiziltan G; Ozekmekçi S; Ertan S; Ertan T; Erginöz E
    J Neurol; 2007 Apr; 254(4):448-52. PubMed ID: 17401525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Exogenous psychoses in Parkinson syndrome. Frequency and causal conditions].
    Schneider E; Fischer PA; Jacobi P; Grotz A
    Fortschr Neurol Psychiatr; 1984 Jun; 52(6):207-14. PubMed ID: 6745832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Levodopa dependency in Parkinson's disease: case report and review].
    Müller U; Reuter M; Hermann W; Gertz HJ
    Nervenarzt; 2002 Sep; 73(9):887-91. PubMed ID: 12215883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis.
    Nausieda PA; Weiner WJ; Kaplan LR; Weber S; Klawans HL
    Clin Neuropharmacol; 1982; 5(2):183-94. PubMed ID: 7139632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic nucleus stimulation for Parkinson disease with severe medication-induced hallucinations or delusions.
    Umemura A; Oka Y; Okita K; Matsukawa N; Yamada K
    J Neurosurg; 2011 Jun; 114(6):1701-5. PubMed ID: 21375379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Levodopa-induced psychosis in patients with idiopathic Parkinson disease].
    García-Escrig M; Bermejo Pareja F; Fernández Ponsatí JT
    Med Clin (Barc); 1999 Feb; 112(7):245-50. PubMed ID: 10220750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease.
    Ruggieri S; De Pandis MF; Bonamartini A; Vacca L; Stocchi F
    Clin Neuropharmacol; 1997 Jun; 20(3):204-9. PubMed ID: 9197942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychiatric manifestations induced by dopamine precursors or antagonists].
    Leger JM; Dumond JJ; Garoux R; Lombertie E; Dumas M
    Ann Med Psychol (Paris); 1979 Nov; 137(9):899-908. PubMed ID: 398173
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychotic complications of long-term levodopa treatment of Parkinson's disease.
    Friedman A; Sienkiewicz J
    Acta Neurol Scand; 1991 Aug; 84(2):111-3. PubMed ID: 1950448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa: long-term impact on Parkinson's disease.
    Br Med J (Clin Res Ed); 1981 Feb; 282(6262):417-8. PubMed ID: 6780051
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychiatric side effects during the treatment of Parkinson's disease.
    Klawans HL
    J Neural Transm Suppl; 1988; 27():117-22. PubMed ID: 3042909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine improves psychotic symptoms and cognition in Parkinson's disease.
    Juncos JL; Roberts VJ; Evatt ML; Jewart RD; Wood CD; Potter LS; Jou HC; Yeung PP
    Mov Disord; 2004 Jan; 19(1):29-35. PubMed ID: 14743357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease: drug-induced psychiatric states.
    Factor SA; Molho ES; Podskalny GD; Brown D
    Adv Neurol; 1995; 65():115-38. PubMed ID: 7872135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates].
    Kashihara K; Ohno M; Katsu Y
    Rinsho Shinkeigaku; 2005 Jan; 45(1):1-5. PubMed ID: 15714992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor complications associated with chronic levodopa therapy in Parkinson's disease.
    Obeso JA; Grandas F; Vaamonde J; Luquin MR; Artieda J; Lera G; Rodriguez ME; Martinez-Lage JM
    Neurology; 1989 Nov; 39(11 Suppl 2):11-9. PubMed ID: 2685647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute psychoses and mood disorders in Parkinson disease. Role of antiparkinson therapy].
    Mouren P; Poinso Y; Oppenheim G; Mouren A; Nguyen Quang N
    Ann Med Psychol (Paris); 1983; 141(8):843-57. PubMed ID: 6666915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
    Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.